TrialCritical care (London, England)2025

A phase 2 randomized, placebo-controlled trial of inulin for the prevention of gut pathogen colonization and infection among patients admitted to the intensive care unit for sepsis.

Heekuk Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.